Lista de obras -

Change in the Recurrence Pattern and Predictors over Time after Complete Cure of Hepatocellular Carcinoma

scientific article published on 26 August 2020

Comparison of Sorafenib versus Hepatic Arterial Infusion Chemotherapy-Based Treatment for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis

scientific article published on 22 April 2020

Differential Impact of Serum 25-Hydroxyvitamin D3 Levels on the Prognosis of Patients with Liver Cirrhosis According to MELD and Child-Pugh Scores

artículo científico publicado en 2020

Direct Bilirubin Is More Valuable than Total Bilirubin for Predicting Prognosis in Patients with Liver Cirrhosis

scientific article published on 09 December 2020

Discontinuation of nucleos(t)ide analogues is not associated with a higher risk of HBsAg seroreversion after antiviral-induced HBsAg seroclearance: a nationwide multicentre study

artículo científico publicado en 2020

Evaluation of Treatment Response after Endoscopic Variceal Obturation with Abdominal Computed Tomography

scientific article published on 01 January 2020

Extremely low risk of hepatocellular carcinoma development in patients with chronic hepatitis B in immune-tolerant phase

scientific article published on 26 May 2020

Maintaining Antiviral Efficacy after Switching to Generic Entecavir 1 mg for Antiviral-resistant Chronic Hepatitis B

artículo científico publicado en 2020

Microbiome as a potential diagnostic and predictive biomarker in severe alcoholic hepatitis

scientific article published on 02 December 2020

Partial Virological Response after 2 Years of Entecavir Therapy Increases the Risk of Hepatocellular Carcinoma in Patients with Hepatitis B Virusassociated Cirrhosis

artículo científico publicado en 2020

Prediction of the varices needing treatment with non-invasive tests in patients with compensated advanced chronic liver disease

scientific article published on 06 February 2019

Predictive score for hepatocellular carcinoma after hepatitis B eantigen loss in patients treated with entecavir or tenofovir

scientific article published on 07 May 2020

Prognosis predictability of serum and urine renal markers in patients with decompensated cirrhosis: A multicenter prospective study

artículo científico publicado en 2020

Prognostic assessment using a new substaging system for Barcelona clinic liver cancer stage C hepatocellular carcinoma: A nationwide study

scientific article published on 07 May 2019

Switching to tenofovir vs continuing entecavir for hepatitis B virus with partial virologic response to entecavir: a randomized controlled trial

artículo científico publicado en 2018

Tenofovir-based combination therapy or monotherapy for multi-drug resistant chronic hepatitis B: Long-term data from a multicenter cohort study

artículo científico publicado en 2020

Vaccinia-based oncolytic immunotherapy Pexastimogene Devacirepvec in patients with advanced hepatocellular carcinoma after sorafenib failure: a randomized multicenter Phase IIb trial (TRAVERSE)

scientific article published on 03 June 2019

Lista de obras de

Change in the Recurrence Pattern and Predictors over Time after Complete Cure of Hepatocellular Carcinoma

Comparison of Sorafenib versus Hepatic Arterial Infusion Chemotherapy-Based Treatment for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis

Differential Impact of Serum 25-Hydroxyvitamin D3 Levels on the Prognosis of Patients with Liver Cirrhosis According to MELD and Child-Pugh Scores

Direct Bilirubin Is More Valuable than Total Bilirubin for Predicting Prognosis in Patients with Liver Cirrhosis

Discontinuation of nucleos(t)ide analogues is not associated with a higher risk of HBsAg seroreversion after antiviral-induced HBsAg seroclearance: a nationwide multicentre study

Evaluation of Treatment Response after Endoscopic Variceal Obturation with Abdominal Computed Tomography

Extremely low risk of hepatocellular carcinoma development in patients with chronic hepatitis B in immune-tolerant phase

Maintaining Antiviral Efficacy after Switching to Generic Entecavir 1 mg for Antiviral-resistant Chronic Hepatitis B

Microbiome as a potential diagnostic and predictive biomarker in severe alcoholic hepatitis

Partial Virological Response after 2 Years of Entecavir Therapy Increases the Risk of Hepatocellular Carcinoma in Patients with Hepatitis B Virusassociated Cirrhosis

Prediction of the varices needing treatment with non-invasive tests in patients with compensated advanced chronic liver disease

Predictive score for hepatocellular carcinoma after hepatitis B eantigen loss in patients treated with entecavir or tenofovir

Prognosis predictability of serum and urine renal markers in patients with decompensated cirrhosis: A multicenter prospective study

Prognostic assessment using a new substaging system for Barcelona clinic liver cancer stage C hepatocellular carcinoma: A nationwide study

Switching to tenofovir vs continuing entecavir for hepatitis B virus with partial virologic response to entecavir: a randomized controlled trial

Tenofovir-based combination therapy or monotherapy for multi-drug resistant chronic hepatitis B: Long-term data from a multicenter cohort study

Vaccinia-based oncolytic immunotherapy Pexastimogene Devacirepvec in patients with advanced hepatocellular carcinoma after sorafenib failure: a randomized multicenter Phase IIb trial (TRAVERSE)